论文部分内容阅读
目的:副腮腺病变在临床上并不多见,本研究旨在探讨副腮腺病变的临床表现、治疗和预后。方法:回顾性分析1999年4月—2008年11月收治的32例副腮腺病变患者的临床资料,包括性别、年龄、病程、症状、体格检查、影像学检查、治疗方案、术后病理检查和随访结果。结果:32例患者中,男8例,女24例,就诊年龄19~69岁,平均45岁。患者通常无明显的症状和体征,病变质地中等或偏硬,活动度良好,界限清楚。所有患者均接受手术治疗,术后病理诊断24例为良性病变(多形性腺瘤19例,良性淋巴上皮瘤3例,基底细胞腺瘤和慢性炎症各1例),8例为恶性病变(腺泡细胞癌和淋巴上皮癌各2例,乳头状囊腺癌、基底细胞癌、上皮-肌上皮癌和黏液表皮样癌各1例),恶性肿瘤患者术后追加放疗。随访12~128个月,平均36个月,预后良好,未见肿瘤复发。结论:副腮腺病变临床少见,其临床表现与良性肿瘤类似,治疗以手术为主,恶性肿瘤可追加术后放疗,预后较好。
Objective: Parotid gland lesions are rare in clinical practice, the purpose of this study is to investigate the clinical manifestations, treatment and prognosis of parotid gland lesions. Methods: The clinical data of 32 cases of accessory parotid lesions admitted from April 1999 to November 2008 were retrospectively analyzed. The data including gender, age, course of disease, symptoms, physical examination, imaging examination, treatment plan, postoperative pathological examination and Follow-up results. Results: Of the 32 patients, 8 were males and 24 were females. The treatment ages ranged from 19 to 69 years with an average of 45 years. Patients usually have no obvious symptoms and signs, lesions medium or rigid, good activity, well-defined. All patients underwent surgical treatment. Twenty-four patients were pathologically diagnosed as benign lesions (19 pleomorphic adenomas, 3 benign lymphoepitheliomas, 1 basal cell adenoma and 1 chronic chronic inflammation), and 8 were malignant 2 cases of vesicular and lymphoepithelial carcinoma, 1 case of papillary cystadenocarcinoma, basal cell carcinoma, epithelial-myoepithelial carcinoma and mucoepidermoid carcinoma, respectively). Patients with malignant tumors were additionally treated with radiotherapy. All cases were followed up for 12 to 128 months with an average of 36 months. The prognosis was good and no tumor recurrence was found. Conclusions: The clinical manifestations of accessory parotid glands are rare and their clinical manifestations are similar to that of benign tumors. Surgical treatment is the main treatment. Malignant tumors may be treated with postoperative radiotherapy and the prognosis is good.